Vimta Labs Ltd
company logo

Vimta Labs Ltd

VIMTALABS Share Price

BSE:524394

NSE:VIMTALABS

478.25

3 (0.63%)

As on April 17, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

475.25

473.80

166444

7.96

2

Fundamentals

2,133.63Cr

35.10

6.22

0.06

13.61

0.21%

76.74

About

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials. During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006. During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company. In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.

S P Vasireddi

1990

VIMTALABS

NameDesignation
S P VasireddiExecutive Chairman
V HarrimanDirector (Operation)
V V Prasad Executive Director
Harita VasireddiManaging Director
Y Prameela RaniNon Executive & Independent Director
Sujani VasireddiCompany Sec. & Compli. Officer
T S Ajai Director
G Purnachandra RaoNon Executive & Independent Director
Subba Rao Pavuluri Director
Sanjay DaveNon Executive & Independent Director
D Balasubramanian Director
A Venkata Ramana Company Secretary
Satya Sreenivas NeerukondaExecutive Director
Yadagiri R PendriNon Executive & Independent Director
Rao Purnachandra Potharlanka Additional Director

Vimta Labs Ltd FAQs

How do I Buy Vimta Labs Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Vimta Labs Ltd shares in BlinkX.

What is the Share Price of Vimta Labs Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Vimta Labs Ltd's share price is ₹478.25 as of 2026-04-19.

What is the PE ratio of Vimta Labs Ltd?

close

Vimta Labs Ltd's P/E ratio is 35.1 times as of 2026-04-19.

What is the PB ratio of Vimta Labs Ltd?

close

Vimta Labs Ltd's most recent financial reports indicate a price-to-book ratio of 6.22, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Vimta Labs Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Vimta Labs Ltd's market capitalization is ₹2133.63 Cr as on 2026-04-19.

What is the ROE of Vimta Labs Ltd?

close

The current financial records of Vimta Labs Ltd show a 19.44% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Vimta Labs Ltd?

close

According to Vimta Labs Ltd's most recent financial filings, the company has a total asset value of ₹194.6, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Vimta Labs Ltd?

close

The 52-week high/low price of a Vimta Labs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Vimta Labs Ltd's 52-week high and low as of 2026-04-19 are ₹902.65 and ₹376.05, respectively.